ReWalk Robotics (NASDAQ:RWLK) versus Medartis (OTCMKTS:MDRSF) Head to Head Analysis

ReWalk Robotics (NASDAQ:RWLKGet Free Report) and Medartis (OTCMKTS:MDRSFGet Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, valuation, profitability, dividends, risk and analyst recommendations.


This table compares ReWalk Robotics and Medartis’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ReWalk Robotics -238.35% -29.00% -25.27%
Medartis N/A N/A N/A

Institutional & Insider Ownership

3.6% of ReWalk Robotics shares are held by institutional investors. 2.1% of ReWalk Robotics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares ReWalk Robotics and Medartis’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
ReWalk Robotics $5.51 million 0.00 -$19.57 million ($0.37) N/A
Medartis N/A N/A N/A N/A N/A

Medartis has lower revenue, but higher earnings than ReWalk Robotics.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for ReWalk Robotics and Medartis, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ReWalk Robotics 0 0 1 0 3.00
Medartis 0 0 0 0 N/A

ReWalk Robotics presently has a consensus price target of $3.00, indicating a potential upside of ∞. Given ReWalk Robotics’ higher possible upside, analysts clearly believe ReWalk Robotics is more favorable than Medartis.


ReWalk Robotics beats Medartis on 5 of the 8 factors compared between the two stocks.

About ReWalk Robotics

(Get Free Report)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.

About Medartis

(Get Free Report)

Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. It serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.

Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with's FREE daily email newsletter.